Prahlad Singh was appointed President and Chief Executive Officer of PerkinElmer in December 2019. He joined the Company in 2014 as President of the Diagnostics business. He was named Executive Vice President in 2016, and in 2019 assumed responsibility as President and Chief Operating Officer of PerkinElmer.
Prior to joining PerkinElmer, Prahlad served as General Manager of General Electric’s Women’s Health business. Previously, he held senior executive level roles at both GE and Philips Healthcare in Strategy, Business Development and M&A. From 1995 to 2007, he held leadership roles of increasing responsibility at DuPont Pharmaceuticals and subsequently Bristol Myers Squibb Medical Imaging which included managing the Asia Pacific and Middle East region. Prahlad holds a Ph.D. in Chemistry from the University of Missouri-Columbia and an M.B.A. from Northeastern University. Prahlad’s technical work has resulted in several peer reviewed publications and global patents.